Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley A Vo

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2012
Desensitization offers hope to highly HLA-sensitized patients for a longer life expectancy after incompatible kidney transplantStanley C Jordan, Ashley A Vo
Current Opinion in Organ Transplantation|October 12, 2014
Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approachesStanley C Jordan, Ashley A Vo
Clinical Transplants|August 7, 2014
Evolving concepts in desensitizationStanley C Jordan, Ashley A Vo
Expert Review of Clinical Immunology|October 29, 2010
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Joseph Kahwaji, Ashley A Vo, Stanley C Jordan
Contributions to Nephrology|November 13, 2008
Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipientsStanley C Jordan, Alice Peng, Ashley A Vo
Transplantation|July 9, 2009
Intravenous immunoglobulin a natural regulator of immunity and inflammationStanley C Jordan, Mieko Toyoda, Ashley A Vo
AACN Advanced Critical Care|June 2, 2026
Clinical Immunology for Heart Transplant Nurses: Medication Decision-MakingBernice Coleman, Ariz Amoroso Guzman, Ashley A Vo
Expert Review of Clinical Immunology|May 21, 2011
Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantationStanley C Jordan, Mieko Toyoda, Ashley A Vo
Clinical Transplants|September 25, 2004
Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experienceStanley C Jordan, Ashley A Vo, Cynthia C Nast, et al.
Pediatric Transplantation|March 25, 2005
Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejectionStanley C Jordan, Ashley A Vo, Mieko Toyoda, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2012
Desensitization offers hope to highly HLA-sensitized patients for a longer life expectancy after incompatible kidney transplantStanley C Jordan, Ashley A Vo
Current Opinion in Organ Transplantation|October 12, 2014
Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approachesStanley C Jordan, Ashley A Vo
Clinical Transplants|August 7, 2014
Evolving concepts in desensitizationStanley C Jordan, Ashley A Vo
Expert Review of Clinical Immunology|October 29, 2010
ABO blood group incompatibility: a diminishing barrier to successful kidney transplantation?Joseph Kahwaji, Ashley A Vo, Stanley C Jordan
Contributions to Nephrology|November 13, 2008
Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipientsStanley C Jordan, Alice Peng, Ashley A Vo
Transplantation|July 9, 2009
Intravenous immunoglobulin a natural regulator of immunity and inflammationStanley C Jordan, Mieko Toyoda, Ashley A Vo
AACN Advanced Critical Care|June 2, 2026
Clinical Immunology for Heart Transplant Nurses: Medication Decision-MakingBernice Coleman, Ariz Amoroso Guzman, Ashley A Vo
Expert Review of Clinical Immunology|May 21, 2011
Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantationStanley C Jordan, Mieko Toyoda, Ashley A Vo
Clinical Transplants|September 25, 2004
Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experienceStanley C Jordan, Ashley A Vo, Cynthia C Nast, et al.
Pediatric Transplantation|March 25, 2005
Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejectionStanley C Jordan, Ashley A Vo, Mieko Toyoda, et al.
Pageof 4